3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
30
Oropharyngeal Neoplasms
21
Nasopharyngeal Carcinoma
15
Head and Neck Neoplasms
13
Prostatic Neoplasms
11
Laryngeal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Carcinoma, Squamous Cell
8
Carcinoma
8
Breast Neoplasms
8
Rectal Neoplasms
7
Mouth Neoplasms
7
Hypopharyngeal Neoplasms
7
Glioma
6
Glioblastoma
6
Uterine Cervical Neoplasms
5
Papillomavirus Infections
5
Esophageal Neoplasms
5
Urinary Bladder Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Nasopharyngeal Neoplasms
4
Astrocytoma
4
Mesothelioma, Malignant
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Tumor Virus Infections
2
Tongue Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Interventions
pegaspargase
5
tislelizumab
2
selinexor
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Azacitidine
2
Asparaginase
2
sugemalimab
1
relatlimab
1
pembrolizumab
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
Vorinostat
1
Valganciclovir
1
Transplantation
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Sirolimus
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Radiotherapy, Intensity-Modulated
×
1 year
×
Clear all
No trials found.